Lewisia disepala

Lewisia disepala (Yosemite Lewisia): A Reference Article

1. Identity and Botanical Classification

Taxonomic Names and Synonymy

Lewisia disepala is a species of flowering plant in the family Montiaceae known by the common name Yosemite lewisia. The species was formally described by the botanist Per Axel Rydberg, and its full accepted name is Lewisia disepala Rydb. Its basionym is Lewisia rediviva var. yosemitana K. Brandegee, published in the Proceedings of the California Academy of Sciences, ser. 2, 4: 89, in 1894.

The USDA Plants Database lists it under the symbol LEDI3, with the common name Yosemite lewisia, previously assigned to the family Portulacaceae, category Dicot, Division Magnoliophyta, and noted as native to the United States, with state distribution limited to California. The family Montiaceae was newly adopted in the APG III system and includes members of the Caryophyllales formerly listed in Portulacaceae. The genus name Lewisia itself commemorates the explorer Meriwether Lewis. The genus Lewisia is named for the American explorer Meriwether Lewis (1774–1809), who encountered the genus in 1806.

The epithet disepala refers to the plant's characteristic two-sepal flower structure, which is among the distinguishing features separating it from other Lewisia species. Flowers are sessile to subsessile and disarticulate in fruit; sepals number 2, broadly obovate to broadly ovate, 7–8 mm, scarious at anthesis, with entire margins and a rounded or sometimes emarginate apex; petals number 5–8, pale-rose-pink, oblanceolate to broadly obovate, 13–18 mm with an obtuse apex; stamens number 1–15; stigmas number 4.

Morphological Description

Lewisia disepala is a petite perennial herb growing from a thick branching taproot and short caudex unit. It produces a basal rosette of many small leaves no more than 1.5 centimeters (0.59 in) long. The leaves are thick, fleshy, hairless, deep shiny green, and club-shaped, knobby, or finger-like, clumped tightly together. The inflorescence has a stem so short that the flowers sit directly on the basal rosette of leaves, or among them. Each flower has 5 to 8 pale to bright pink oval petals and 15 protruding stamens.

According to the Flora of North America, taproots gradually ramify distally. Stems are erect, 0.5–3 cm. Basal leaves are withering at or soon after anthesis, sessile, blade linear to slightly clavate, terete, 0.8–2 cm, margins entire, apex obtuse; cauline leaves are absent. Inflorescences bear flowers singly; bracts 2–4, proximal in 1 pair, ovate to lanceolate, 2–3 mm, margins entire, apex acute. Seeds number 11–15 and measure 2.8–3.5 mm.

Members of the broader family to which Lewisia disepala belongs share characteristic anatomical traits. The mesophyll of Portulacaceae/Montiaceae plants usually contains mucilage cells. Seeds contain starch. At the family level, proanthocyanidins are present or absent; when present, cyanidin is the type found. Flavonols are present or absent; when present, kaempferol is documented. Saponins/sapogenins may also be present or absent, and plants often accumulate free oxalates.

Natural Habitat and Conservation Status

Lewisia disepala is endemic to the Sierra Nevada of California, where it is known from several sites high in the mountains. It grows in rocky mountain habitat such as talus and open beds of bare gravel. It is of conservation concern, and is known only from scattered localities in the southern Sierra Nevada.

Lewisia disepala Rydb. carries the California Rare Plant Rank of 1B.2, meaning it is rare, threatened, or endangered in California and elsewhere. It is included in the CNPS inventory of rare and endangered plants, with a designation of "rare, threatened, or endangered in California and elsewhere," and CNPS itself reports a mere 22 known sites. Removing, picking, or otherwise disturbing plants at its known locations is illegal under California law.

Flowering occurs from late winter to mid- (or late) spring.

Common Names and Forms Available

The plant is known almost exclusively as Yosemite lewisia or, occasionally, Yosemite bitter-root, reflecting both its geographic restriction and its relationship to the better-known bitter-root (Lewisia rediviva). Because of its extreme rarity and legal protected status, Lewisia disepala is not commercially cultivated at any meaningful scale as a botanical raw material. In the limited contemporary supplement market that references this species, the root is the plant part cited as the source material; ethnobotanical records highlight the root as the part historically consumed as a food source and incorporated into remedies.

2. The Genus Lewisia: Broader Context

The native habitat of Lewisia species is rocky ground and cliffs in western North America. Lewisias are succulent perennial plants native to western North American habitats including rocky outcrops from the high elevation alpine to lower elevation chaparral, oak woodlands, and coniferous forests. There are nineteen species and several varieties of Lewisia. About half of the species of Lewisia are deciduous, including the original Lewisia rediviva. Some species, such as Lewisia cotyledon, are evergreen.

Lewisia is a genus of western North America species in the family Montiaceae (previously Portulacaceae). Members usually have a rosette of fleshy leaves that resemble a succulent, and may be produced from a thickened taproot or tuber. Some species pass the long arid season by becoming dormant.

The genus Lewisia was moved in 2009 from the purslane family (Portulacaceae), with adoption of the APG III system, to the family Montiaceae. This reclassification was supported by molecular phylogenetic evidence demonstrating that the traditional Portulacaceae as delimited was paraphyletic.

3. Traditional and Historical Use

Ethnobotanical Context: The Genus Broadly

Native Americans ate the roots of Lewisia species, which have also been used to treat sore throats. The best-documented ethnobotanical record for the genus pertains to the closely related Lewisia rediviva (bitterroot), which has been intensively studied. Understanding this record is relevant to Lewisia disepala because both species share the same root morphology, the same family, a nearly identical habitat type, and close phylogenetic proximity; L. disepala was itself previously treated as a variety of L. rediviva.

For Lewisia rediviva, the Native American Ethnobotany Database documents use by a wide variety of California, Great Basin, and Plateau peoples: documented uses include food—dried food, unspecified food, and winter-use food—by the Paiute, Northern Paiute, and Okanagon, among others, with records sourced from historical ethnobotanical monographs dating to the early twentieth century.

The roots of bitterroot were consumed by tribes such as the Shoshone and Flathead Indians as an infrequent delicacy. Traditionally, the Ktunaxa cooked bitterroot with grouse. For the Ktunaxa, bitterroot is eaten with sugar; other tribes prefer eating it with salt. The Lemhi Shoshone believed the small red core found in the upper taproot had special powers, notably being able to stop a bear attack. Plains Indians peeled and boiled the root prior to its consumption.

Traditional Use Specifically Attributed to Lewisia disepala

It is important to note that the great majority of formal ethnobotanical literature pertains to Lewisia rediviva, not specifically to Lewisia disepala. L. disepala is restricted to the southern Sierra Nevada; accordingly, any traditional use would have been by peoples inhabiting that range. One secondary source, a supplement ingredient database, states: traditionally, the roots of Lewisia disepala were highly valued for their nutritional and therapeutic properties. Native American tribes, such as the Shoshone and Paiute, would harvest and dry the roots for year-round use, utilizing them as a vital food source and in various healing remedies. The roots were often boiled or roasted to enhance their digestibility and flavor.

Medicinally, Lewisia disepala was employed to address digestive ailments, including stomach discomfort and indigestion. The plant's demulcent qualities were believed to soothe internal membranes. Additionally, poultices made from the mashed root were applied externally to reduce swelling and inflammation, exemplifying the herb's versatility in traditional healing practices.

Important caveat: These specific claims about Lewisia disepala's traditional medicinal use (as distinct from food use) are reproduced in supplement marketing contexts and are not independently corroborated in peer-reviewed ethnobotanical literature or primary historical ethnographic sources found during this review. Readers should understand that the CNPS rates L. disepala as having only approximately 22 known sites, making extensive pre-contact harvest for medicinal purposes less plausible than for the far more abundant L. rediviva. Caution is therefore appropriate in treating these traditional-use claims as established fact.

Food Use in the Broader Lewisia Tradition

The genus's role as a food plant is well-established for Lewisia rediviva and generalizable, with appropriate caveats, across the genus: the bitter root plant holds significant cultural importance among Native American tribes, where it is used both as a staple food and a ceremonial item. The name 'bitter root' derives from the intensely bitter taste of the plant's fleshy taproot. The plant was already well known by the Native peoples of America, including the Cheyenne, Ktunaxa, Shoshone, and Nez Perce, among many others.

Peoples including the Washoe (California, Nevada), Owens Valley Paiute (California), Northern Paiute (California, Idaho, Nevada, Oregon), and Southern Paiute (Utah) knew bitterroot for at least 10,000 years before European contact. Given that Lewisia disepala occupies Sierra Nevada habitats historically inhabited by Paiute and Miwok groups, an analogous food use is plausible but should not be assumed to mirror the specific traditions documented for L. rediviva.

4. Key Constituents and Phytochemistry

State of Knowledge

There are no published peer-reviewed phytochemical studies specifically characterizing the chemical composition of Lewisia disepala identified in this review. All chemical information that can be responsibly attributed to L. disepala derives either from (a) the family-level and genus-level chemistry of Montiaceae/Portulacaceae, or (b) extrapolation from other, better-studied Lewisia species. This limitation must be stated plainly upfront.

Family-Level Phytochemistry (Montiaceae / Portulacaceae)

Portulacaceae/Montiaceae shrubs and herbs are commonly mucilaginous in leaves and stems. At the family level, the following compound classes have been characterized:

• Starch: Seeds contain starch.
• Mucilage: The mesophyll usually contains mucilage cells.
• Proanthocyanidins (condensed tannins): Present or absent; when present, of the cyanidin type.
• Flavonols: Present or absent; when present, kaempferol is documented.
• Saponins/sapogenins: Present or absent depending on species.
• Free oxalates: Plants in this family often accumulate free oxalates.
• Alkaloids: Alkaloids are generally absent in Portulacaceae/Montiaceae.

For the closely related family member Portulaca oleracea (purslane), formal studies have identified a richer compound inventory: diverse compounds have been isolated from Portulaca oleracea, such as flavonoids, alkaloids, polysaccharides, fatty acids, terpenoids, sterols, proteins, vitamins, and minerals. However, extrapolating this specific profile to Lewisia disepala without direct phytochemical analysis would be speculative.

Genus-Level Chemistry: Extrapolations from Related Species

Recent phytochemical investigations into related species of the Lewisia genus suggest the presence of beneficial compounds such as polysaccharides, phenolics, and flavonoids, which are known to contribute antioxidant and anti-inflammatory effects in other botanicals. However, direct scientific validation of these effects in Lewisia disepala is still in its early stages.

No peer-reviewed publications specifically identifying polysaccharide fractions, phenolic acid profiles, flavonoid glycosides, or other discrete phytochemicals from Lewisia disepala root, leaf, or flower were found in this review. Claims about specific active molecules in L. disepala that appear in supplement marketing materials cannot be verified against primary scientific literature and are therefore omitted from this article.

Nutritional Composition of the Root (Genus-Level Context)

In the context of Lewisia rediviva as a food plant, the thick taproot is recognized as a calorie-dense carbohydrate food. The root is notably bitter when raw, which is attributed to compounds that are partially removed or altered by boiling. The starchy nature of Lewisia taproots, consistent with the family-level characterization of starch-containing seeds and mucilaginous tissues, supports a role as a caloric staple. Beyond carbohydrates and mucilage, the specific micronutrient and secondary metabolite profile of L. disepala root has not been published in accessible peer-reviewed literature.

5. Scientific Evidence by Area of Use

5.1 Overall Evidence Status

To date, no large-scale clinical trials have assessed the efficacy or safety profile of Lewisia disepala in humans, and most available evidence remains anecdotal or based on traditional usage reports. This is an overarching fact that governs every subsection below. No randomized controlled trials, systematic reviews, meta-analyses, or formal human pharmacokinetic studies for Lewisia disepala were identified in PubMed, PMC, or any other peer-reviewed database consulted for this review.

5.2 Digestive Health

The primary area of traditionally attributed medicinal use for Lewisia disepala is digestive health. Medicinally, the plant was employed to address digestive ailments, including stomach discomfort and indigestion. The plant's demulcent qualities were believed to soothe internal membranes and promote gastrointestinal well-being. These claims rest exclusively on traditional-use attribution and have not been tested in animal models or human subjects specific to this species.

Evidence strength: No scientific evidence. The attributed gastrointestinal effects derive from traditional use reports and plausible, but unverified, inferences from the family-level presence of mucilage.

5.3 Wound Healing and Topical Applications

Some traditional uses have been cited supporting the use of Lewisia disepala for treating cuts; however, no clinical or pharmacological studies have assessed its efficacy or safety for wound healing. Poultice application of the mashed root is mentioned in some secondary sources as a traditional practice for external swelling, but no primary ethnographic documents or experimental studies could be found to corroborate this.

Evidence strength: No scientific evidence.

5.4 Anti-inflammatory Activity

No in vitro, animal, or human studies examining the anti-inflammatory potential of Lewisia disepala extracts were identified. Inferences drawn in commercial contexts rely on the documented anti-inflammatory activity of phenolics and flavonoids in other plant species, extrapolated to L. disepala on the basis of presumed phytochemical similarity. This extrapolation is not scientifically established for this species.

Evidence strength: No scientific evidence specific to this species.

5.5 Antioxidant Activity

By analogy with related Montiaceae and with plant phenolics generally, antioxidant activity has been speculated. Phytochemical investigations into related Lewisia genus species suggest the presence of polysaccharides, phenolics, and flavonoids, which are known to contribute antioxidant effects in other botanicals. No assays (DPPH, FRAP, ORAC, or otherwise) using Lewisia disepala material have been published in peer-reviewed literature.

Evidence strength: No scientific evidence specific to this species.

5.6 Nutritional and Metabolic Effects

Lewisia disepala has been traditionally valued by Indigenous peoples for its potential nutritional properties. Its roots, in particular, were historically consumed as a food source and incorporated into remedies for digestive and metabolic conditions. No human nutritional studies, metabolic studies, or glycemic/lipid outcome studies have been conducted using L. disepala.

Evidence strength: Traditional use only; no clinical or experimental evidence.

6. Body Systems and Health Areas Associated With This Plant

Based on the traditional-use literature attributable to Lewisia disepala and the broader genus, the following body systems and health areas have been associated with this plant, with the explicit caveat that no clinical evidence exists for any of these associations:

• Gastrointestinal system: Historically attributed demulcent activity, soothing of mucous membranes, and support of digestive comfort. Associated preparation: root decoction (boiled root).
• Integumentary system (skin/wounds): Topical poultice use for swelling and external irritation attributed in some secondary sources.
• General nutrition and caloric sustenance: The starchy taproot served as a significant energy-dense food for Indigenous peoples of the Sierra Nevada region.
• Immune/inflammatory systems (speculative): Inferred by extrapolation from related species' phytochemistry; no direct evidence for L. disepala.

7. Dosage Forms and Reported Dosages

No clinical or experimental studies have established any dosage for Lewisia disepala in any form. Accordingly, no specific milligram doses, standardized extract concentrations, or dosing frequencies can be responsibly reported here.

In terms of traditional preparations, available secondary sources describe:

• Boiled or roasted root: The roots were often boiled or roasted to enhance their digestibility and flavor.
• Dried root for storage: Roots were incorporated into remedies and as a food source, implying drying for preservation.
• Poultice: Poultices made from the mashed root were applied externally.

In the contemporary supplement market, Lewisia disepala has appeared as a listed ingredient in certain nutritional formulations, typically without disclosed standardization or dosage information. No peer-reviewed or regulatory document specifying a dose was located. The plant is not listed in any pharmacopeia (USP, European Pharmacopoeia, WHO monographs), nor in the ESCOP or German Commission E monographs.

8. Safety Considerations

Absence of Formal Safety Data

To date, no large-scale clinical trials have assessed the safety profile of Lewisia disepala in humans. No clinical or pharmacological studies have assessed its safety. There are no published toxicological studies (acute, subacute, subchronic, or chronic) using Lewisia disepala extracts or isolated fractions in animals or humans.

Oxalate Content

A meaningful safety consideration applicable at the family level is oxalate accumulation. Plants in the Portulacaceae/Montiaceae family often accumulate free oxalates. High dietary oxalate intake is associated with increased risk of calcium oxalate kidney stone formation in susceptible individuals. Whether Lewisia disepala root contains oxalates at clinically relevant concentrations has not been specifically investigated.

Rarity, Legality, and Sourcing Concerns

Lewisia disepala carries a California Rare Plant Rank of 1B.2, designating it as rare, threatened, or endangered in California and elsewhere. It is included in the CNPS inventory of rare and endangered plants, and CNPS reports a mere 22 known sites. This conservation status means that any wild-harvested material would be subject to legal restrictions in California. The legality of commercial wild harvest is therefore highly questionable, and the sustainability of any harvest from wild populations is deeply problematic given the species' documented rarity.

Supplement products listing Lewisia disepala as an ingredient raise unresolved questions about the actual sourcing, identity verification, and substitution of material, as the species cannot be verified as commercially cultivated at any documented scale.

Drug Interactions

No drug interaction data, pharmacokinetic studies, or cytochrome P450 interaction assays specific to Lewisia disepala have been published. No interaction claims can be responsibly made on the basis of currently available evidence.

Populations Requiring Special Attention

Given the complete absence of safety data, no evidence-based safety conclusions can be drawn regarding pregnancy, lactation, pediatric populations, or individuals with renal or hepatic disease. The theoretical concern about oxalate accumulation (shared across the Montiaceae family) may be of particular relevance to individuals with a history of calcium oxalate nephrolithiasis.

9. Regulatory and Pharmacopeial Status

Lewisia disepala does not appear in the United States Pharmacopeia (USP), the European Pharmacopoeia, WHO Traditional Medicine monographs, ESCOP monographs, or German Commission E monographs. It has no established regulatory status as a dietary ingredient with defined specifications or safety thresholds in any jurisdiction reviewed. The USDA Natural Resources Conservation Service (NRCS) PLANTS database lists the species under symbol LEDI3 strictly as a native California plant; it carries no food or supplement designation.

10. Summary of Evidence Appraisal

Lewisia disepala is a botanically distinctive, legally protected, and extremely rare endemic herb of the southern Sierra Nevada. Its traditional use as a food plant (and, with less reliable documentation, as a medicine) by Indigenous peoples of the region is plausible given its relationship to the well-documented food plant Lewisia rediviva. However, virtually all specific medicinal claims circulating in the dietary supplement context for Lewisia disepala lack peer-reviewed primary evidence. While ethnobotanical records highlight its importance in traditional diets, scientific studies specifically focused on Lewisia disepala remain limited. No human clinical trials, controlled animal studies, formal phytochemical analyses, or pharmacokinetic investigations have been published for this species. Any therapeutic claims made for this ingredient in commercial products must therefore be regarded as unsubstantiated by modern scientific standards.

References

• Wikipedia: Lewisia disepala
• Wikipedia: Lewisia (genus)
• Flora of North America: Lewisia disepala
• Calflora: Lewisia disepala
• Jepson eFlora: Lewisia disepala
• USDA Plant Characteristics: Lewisia disepala (LEDI3)
• Lady Bird Johnson Wildflower Center: Lewisia disepala
• Calscape: Yosemite Lewisia
• Caring Sunshine: Ingredient – Lewisia disepala
• Caring Sunshine: Lewisia disepala and Cuts
• Native American Ethnobotany Database: Lewisia rediviva
• Wikipedia: Lewisia rediviva (Bitterroot)
• Pacific Bulb Society: Lewisia
• Australian National Botanic Gardens: Portulacaceae
• Wikipedia: Montiaceae
• Wikipedia: Portulacaceae
• YosemiteHikes.com: Yosemite Lewisia
• Zhou et al. (2015): Portulaca oleracea — Phytochemistry and Pharmacological Effects. BioMed Research International.
• USDA Forest Service: Kellogg's and Hutchison's Lewisia
• The Soul of the Earth: Living on the ledge — ingenious bitterroot
• Lewis & Clark Trail Heritage Foundation: Bitterroot Plant